Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT02862431 · TERMINATED
Trial details
- NCT number
- NCT02862431
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-12
- Primary completion
- 2016-11-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.